Charlotte's Web Holdings (CWBHF) Income from Continuing Operations (2021 - 2026)
Charlotte's Web Holdings (CWBHF) posted quarterly Income from Continuing Operations of 13112000.0 for Q1 2026, down 111.08% year-over-year from 118389162.79 in Q1 2025, and down 14.79% quarter-over-quarter from 11423000.0 in Q4 2025.
Charlotte's Web Holdings (CWBHF) Income from Continuing Operations (2021 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has reported Income from Continuing Operations for 6 consecutive years, with 13112000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 111.08% year-over-year to 13112000.0; the TTM figure through Mar 2026 stood at 36641000.0 (down 38.67% YoY), while the FY2025 annual figure was 29741000.0, changed 0.35% from the prior year.
- Income from Continuing Operations eased to 13112000.0 in Q1 2026 per CWBHF's latest filing, from 11423000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 2844000.0 in Q2 2023 and bottomed at 35229000.0 in Q4 2022.
- Historically, Income from Continuing Operations has averaged 9165176.47 across 5 years, with a median of 7870000.0 in 2022.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations sank 876.58% — and 2023, when it surged 136.14%.
- Charlotte's Web Holdings' Income from Continuing Operations stood at 35229000.0 in 2022, then surged by 75.63% to 8585000.0 in 2023, then jumped by 60.77% to 3368000.0 in 2024, then plunged by 239.16% to 11423000.0 in 2025, then decreased by 14.79% to 13112000.0 in 2026.
- Business Quant data shows CWBHF's Income from Continuing Operations at 13112000.0 in Q1 2026, 11423000.0 in Q4 2025, and 5818000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Charlotte's Web Holdings | 63.18 Mn | 49.19 Mn | 5.16 Mn | -4.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.13 Mn |
| Mar 31, 2026 | -13.11 Mn |
| Dec 31, 2025 | -11.42 Mn |
| Sep 30, 2025 | -5.82 Mn |
| Jun 30, 2025 | -6.29 Mn |
| Mar 31, 2025 | -6.21 Mn |
| Dec 31, 2024 | -3.37 Mn |
| Sep 30, 2024 | -5.79 Mn |
| Jun 30, 2024 | -11.06 Mn |
| Mar 31, 2024 | -9.63 Mn |
| Dec 31, 2023 | -8.59 Mn |
| Sep 30, 2023 | -15.14 Mn |
| Jun 30, 2023 | 2.84 Mn |
| Mar 31, 2023 | -2.91 Mn |
| Dec 31, 2022 | -35.23 Mn |
| Sep 30, 2022 | -7.59 Mn |
| Jun 30, 2022 | -7.87 Mn |
| Mar 31, 2022 | -8.63 Mn |
| Dec 31, 2021 | -118.25 Mn |
| Sep 30, 2021 | -777,000.00 |